Role of Ayurvedic Nasya Therapy in Managing Dry Age Related Vision Loss.

Effectiveness of Triphala Ghrita Nasya along with Antioxidant Therapy and Antioxidant Therapy alone in the management of Vataja Timira with Reference to Age Related Macular Degeneration (Dry type)- A Randomized Controlled Clinical Trial. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/096836

Enrollment

Registered

2025-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patient with distant vision less than equal to 6/9 with symptoms like bhramativa darshana (objects seems to be moving) avila darshana (blur vision) arunah darshana (slight red) vyavidha darshana (metamorphopsia).

Exclusion criteria

Exclusion criteria: 1.retinal diseases except ARMD dry type 2.systemic diseases which affect macula like uncontrolled DM , hypertention. 3.cataract patients 4.patients contraindicated for nasya

Design outcomes

Primary

Measure	Time frame
Triphala Ghrita Nasya and Antioxidant Therapy is significantly effective than Antioxidant Therapy only in symptoms of Vataj Timir with reference to Age Related Macular Degneration (Dry Type)Timepoint: 0th,7th,14th,21st,28th and 42nd day.	—

Secondary

Measure	Time frame
Triphala Ghrita Nasya and Antioxidant Therapy is not significantly effective than Antioxidant Therapy only in symptoms of Vataj Timir with reference to Age Related Macular Degneration (Dry Type)Timepoint: 0th,7th,14th,21st,28th and 42nd day.	—

Countries

India

Contacts

Public ContactDr Nutan Radaye

Dr.G.D.Pol Foundation ,YMT Ayurvedic Medical College and Hospital

nutan.radaye.nr@gmail.com9820512695

Outcome results